Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Synthesis and structure-activity relationship of N-(2-arylethyl) isoquinoline derivatives as human scavenger receptor CD36 antagonists.

Wang YX, Wang L, Xu YN, Li YH, Jiang JD, Si SY, Li YB, Ren G, Shan YQ, Hong B, Song DQ.

Eur J Med Chem. 2011 Apr;46(4):1066-73. doi: 10.1016/j.ejmech.2011.01.022. Epub 2011 Jan 21.

PMID:
21295889
2.

Synthesis, structure-activity relationship and in vitro biological evaluation of N-arylethyl isoquinoline derivatives as Coxsackievirus B3 inhibitors.

Wang YX, Li YH, Li YH, Gao RM, Wang HQ, Liu YX, Gao LM, Lu QN, Jiang JD, Song DQ.

Bioorg Med Chem Lett. 2011 Oct 1;21(19):5787-90. doi: 10.1016/j.bmcl.2011.08.002. Epub 2011 Aug 8.

PMID:
21880491
3.

Identification of two antagonists of the scavenger receptor CD36 using a high-throughput screening model.

Xu Y, Wang J, Bao Y, Jiang W, Zuo L, Song D, Hong B, Si S.

Anal Biochem. 2010 May 15;400(2):207-12. doi: 10.1016/j.ab.2010.02.003. Epub 2010 Feb 10.

PMID:
20152792
4.
5.

Endocytosis of oxidized low density lipoprotein through scavenger receptor CD36 utilizes a lipid raft pathway that does not require caveolin-1.

Zeng Y, Tao N, Chung KN, Heuser JE, Lublin DM.

J Biol Chem. 2003 Nov 14;278(46):45931-6. Epub 2003 Aug 28.

6.

Discovery of antagonists for human scavenger receptor CD36 via an ELISA-like high-throughput screening assay.

Wang L, Bao Y, Yang Y, Wu Y, Chen X, Si S, Hong B.

J Biomol Screen. 2010 Mar;15(3):239-50. doi: 10.1177/1087057109359686. Epub 2010 Feb 11.

PMID:
20150587
7.

Cd36, a member of the class b scavenger receptor family, as a receptor for advanced glycation end products.

Ohgami N, Nagai R, Ikemoto M, Arai H, Kuniyasu A, Horiuchi S, Nakayama H.

J Biol Chem. 2001 Feb 2;276(5):3195-202. Epub 2000 Oct 16.

8.

Distinct mechanisms for OxLDL uptake and cellular trafficking by class B scavenger receptors CD36 and SR-BI.

Sun B, Boyanovsky BB, Connelly MA, Shridas P, van der Westhuyzen DR, Webb NR.

J Lipid Res. 2007 Dec;48(12):2560-70. Epub 2007 Sep 17.

9.

[Synthesis and structure-activity relationship of N-(2-arylethyl) isoquinoline derivatives as anti-cancer agents].

Wang YX, Zhao WL, Bi CW, Li YB, Shao RG, Song DQ.

Yao Xue Xue Bao. 2012 Feb;47(2):200-5. Chinese.

PMID:
22512031
10.

Adipocytes recognize and degrade oxidized low density lipoprotein through CD36.

Kuniyasu A, Hayashi S, Nakayama H.

Biochem Biophys Res Commun. 2002 Jul 12;295(2):319-23.

PMID:
12150950
11.

Expression of caveolin-1 in hepatic cells increases oxidized LDL uptake and preserves the expression of lipoprotein receptors.

Truong TQ, Brodeur MR, Falstrault L, Rhainds D, Brissette L.

J Cell Biochem. 2009 Nov 1;108(4):906-15. doi: 10.1002/jcb.22321.

PMID:
19718657
12.

Oxidized low-density lipoproteins bind to the scavenger receptor, CD36, of hepatic stellate cells and stimulate extracellular matrix synthesis.

Schneiderhan W, Schmid-Kotsas A, Zhao J, Grünert A, Nüssler A, Weidenbach H, Menke A, Schmid RM, Adler G, Bachem MG.

Hepatology. 2001 Oct;34(4 Pt 1):729-37.

PMID:
11584369
13.

The binding of oxidized low density lipoprotein to mouse CD36 is mediated in part by oxidized phospholipids that are associated with both the lipid and protein moieties of the lipoprotein.

Boullier A, Gillotte KL, Hörkkö S, Green SR, Friedman P, Dennis EA, Witztum JL, Steinberg D, Quehenberger O.

J Biol Chem. 2000 Mar 31;275(13):9163-9.

14.

Plasmodium falciparum-infected erythrocytes and oxidized low-density lipoprotein bind to separate domains of CD36.

Crandall I, Guy RA, Maguire GF, Connelly PW, Kain KC.

J Infect Dis. 1999 Aug;180(2):473-9.

PMID:
10395864
15.

The role of human and mouse hepatic scavenger receptor class B type I (SR-BI) in the selective uptake of low-density lipoprotein-cholesteryl esters.

Rhainds D, Brodeur M, Lapointe J, Charpentier D, Falstrault L, Brissette L.

Biochemistry. 2003 Jun 24;42(24):7527-38.

PMID:
12809509
16.
17.
18.

Low-density lipoprotein from apolipoprotein E-deficient mice induces macrophage lipid accumulation in a CD36 and scavenger receptor class A-dependent manner.

Zhao Z, de Beer MC, Cai L, Asmis R, de Beer FC, de Villiers WJ, van der Westhuyzen DR.

Arterioscler Thromb Vasc Biol. 2005 Jan;25(1):168-73. Epub 2004 Oct 28.

19.

Human CD36 is a high affinity receptor for the native lipoproteins HDL, LDL, and VLDL.

Calvo D, Gómez-Coronado D, Suárez Y, Lasunción MA, Vega MA.

J Lipid Res. 1998 Apr;39(4):777-88.

20.

Identification on human CD36 of a domain (155-183) implicated in binding oxidized low-density lipoproteins (Ox-LDL).

Puente Navazo MD, Daviet L, Ninio E, McGregor JL.

Arterioscler Thromb Vasc Biol. 1996 Aug;16(8):1033-9.

Supplemental Content

Support Center